tradingkey.logo

Hims & Hers Health Inc

HIMS
31.690USD
-2.180-6.44%
收盤 01/09, 16:00美東報價延遲15分鐘
7.21B總市值
52.92本益比TTM

Hims & Hers Health Inc

31.690
-2.180-6.44%

關於 Hims & Hers Health Inc 公司

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Hims & Hers Health Inc簡介

公司代碼HIMS
公司名稱Hims & Hers Health Inc
上市日期Sep 09, 2019
CEODudum (Andrew)
員工數量1637
證券類型Ordinary Share
年結日Sep 09
公司地址2269 Chestnut St
城市SAN FRANCISCO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編94123
電話14158510195
網址https://www.forhims.com/
公司代碼HIMS
上市日期Sep 09, 2019
CEODudum (Andrew)

Hims & Hers Health Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Ms. Andrea Perez
Ms. Andrea Perez
Independent Director
Independent Director
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Mike Chi
Mr. Mike Chi
Chief Operating Officer
Chief Operating Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
業務USD
名稱
營收
佔比
Online
589.10M
98.35%
Wholesale
9.88M
1.65%
地區USD
名稱
營收
佔比
United States
598.98M
100.00%
業務
地區
業務USD
名稱
營收
佔比
Online
589.10M
98.35%
Wholesale
9.88M
1.65%

股東統計

更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
其他
61.71%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
其他
61.71%
股東類型
持股股東
佔比
Investment Advisor
53.26%
Investment Advisor/Hedge Fund
13.37%
Research Firm
12.70%
Hedge Fund
10.85%
Individual Investor
6.37%
Pension Fund
1.81%
Bank and Trust
1.46%
Sovereign Wealth Fund
0.74%
Private Equity
0.23%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1031
207.42M
94.59%
-8.21M
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
22.09M
10.07%
+414.70K
+1.91%
Sep 30, 2025
The Vanguard Group, Inc.
19.47M
8.88%
+841.15K
+4.51%
Sep 30, 2025
Capital World Investors
18.78M
8.57%
+223.89K
+1.21%
Sep 30, 2025
JP Morgan Asset Management
12.87M
5.87%
+12.26M
+2026.69%
Sep 30, 2025
Farallon Capital Management, L.L.C.
10.75M
4.9%
+2.53M
+30.84%
Sep 30, 2025
Dudum (Andrew)
9.50M
4.33%
+73.71K
+0.78%
Dec 15, 2025
Renaissance Technologies LLC
9.10M
4.15%
+2.23M
+32.42%
Sep 30, 2025
Goldman Sachs & Company, Inc.
8.54M
3.9%
+998.73K
+13.24%
Sep 30, 2025
State Street Investment Management (US)
7.17M
3.27%
+132.38K
+1.88%
Sep 30, 2025
Morgan Stanley & Co. LLC
5.93M
2.71%
+1.88M
+46.43%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
First Trust Nasdaq Lux Digi Health Solutions ETF
3.83%
Global X HealthTech ETF
3.75%
Amplify Weight Loss Drug & Treatment ETF
3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
3.66%
YieldMax Ultra Option Income Strategy ETF
2.96%
Invesco S&P MidCap 400 Pure Growth ETF
2.4%
State Street SPDR S&P Health Care Services ETF
1.94%
Amplify Online Retail ETF
1.85%
Invesco S&P MidCap 400 GARP ETF
1.65%
VanEck Social Sentiment ETF
1.53%
查看更多
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比3.83%
Global X HealthTech ETF
佔比3.75%
Amplify Weight Loss Drug & Treatment ETF
佔比3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比3.66%
YieldMax Ultra Option Income Strategy ETF
佔比2.96%
Invesco S&P MidCap 400 Pure Growth ETF
佔比2.4%
State Street SPDR S&P Health Care Services ETF
佔比1.94%
Amplify Online Retail ETF
佔比1.85%
Invesco S&P MidCap 400 GARP ETF
佔比1.65%
VanEck Social Sentiment ETF
佔比1.53%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Hims & Hers Health Inc的前五大股東是誰?

Hims & Hers Health Inc的前五大股東如下:
BlackRock Institutional Trust Company, N.A.
持有股份:22.09M
佔總股份比例:10.07%。
The Vanguard Group, Inc.
持有股份:19.47M
佔總股份比例:8.88%。
Capital World Investors
持有股份:18.78M
佔總股份比例:8.57%。
JP Morgan Asset Management
持有股份:12.87M
佔總股份比例:5.87%。
Farallon Capital Management, L.L.C.
持有股份:10.75M
佔總股份比例:4.90%。

Hims & Hers Health Inc的前三大股東類型是什麼?

Hims & Hers Health Inc 的前三大股東類型分別是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors

有多少機構持有Hims & Hers Health Inc(HIMS)的股份?

截至2025Q4,共有1031家機構持有Hims & Hers Health Inc的股份,合計持有的股份價值約為207.42M,占公司總股份的94.59% 。與2025Q3相比,機構持股有所增加,增幅為5.48%。

哪個業務部門對Hims & Hers Health Inc的收入貢獻最大?

在FY2025Q3,Online業務部門對Hims & Hers Health Inc的收入貢獻最大,創收589.10M,占總收入的98.35% 。
KeyAI